The price of Cefuroxime has increased in the US market in the first half of December of 2025. The increase in Cefuroxime prices was the result of intense procurement strategy of the buyers across the domestic market. The increase was shaped by the measured buying activity from the downstream sectors. The inventory position at the pharmaceutical formulators was tight in early December. The downstream buyers have focused on consuming existing stocks in November which has limited the buffer availability at the start of December. The Cefuroxime buyers have prioritized the supply security to ensure uninterrupted production schedules in winters. The marginal increase of Cefuroxime prices was supported by buyer sentiment of firm procurement. The broader market sentiment was stable without any major disruptions. ChemAnalyst forecasts that the prices of Cefuroxime will likely decrease in the forthcoming period. The stakeholders should make informed procurement and maintain measured pricing strategy.
